Inverse correlation of concurrent BCL2, and C MYC expressions and CD30 ‎positivity as regard the Prognostic significance in diffuse large B-cell ‎lymphoma

Prognostic Significance of Concurrent MYC, BCL2 and/or BCL6 Expression in Diffuse Large B-Cell Lymphoma

DIAGNOSTIC AND PROGNOSTIC VALUE OF NOTCH-2 MUTATIONS IN DIFFUSE LARGE B CELL LYMPHOMA IN EGYPTIAN PATIENTS INFECTED WITH HEPATITIS C VIRUS GENOTYPE 4

Clinicopathological features of relapsed diffuse large B-cell lymphoma: South Egypt Cancer Institute experience

RETROSPECTIVE ANALYSIS OF CLINICO-EPIDEMIOLOGICAL FEATURES AND OUTCOMES OF DIFFUSE LARGE B CELL LYMPHOMA IN ADULT PATIENTS TREATED AT CLINICAL ONCOLOGY DEPARTMENT, AIN SHAMS UNIV

DIAGNOSTIC AND PROGNOSTIC VALUE OF NOTCH-2 MUTATIONS IN DIFFUSE LARGE B-CELL LYMPHOMA IN EGYPTIAN PATIENTS.

Prognostic value of CD10, BCL6 and MUM1 in diffuse large B-cell lymphoma

PROGNOSTIC SIGNIFICANCE OF BCL-2, BAX AND P53 EXPRESSION IN BREAST CANCER

Exploring The Prognostic Significance of Lymphoma in Colon and Rectum, National Cancer Institute Experience, Egypt

Prognostic Value of Soluble HLA-G and CD38 Expression in Patients with Chronic Lymphocytic Leukemia in Egypt